APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tuberculosis Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Tuberculosis Vaccine Industry Growth and Trends Forecast to 2032

28 December 2025106 pages

Choose your research edition.

Industry ResearchTuberculosis Vaccine Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Tuberculosis Vaccine Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Tuberculosis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tuberculosis Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Tuberculosis Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Tuberculosis Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Tuberculosis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Tuberculosis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tuberculosis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tuberculosis Vaccine include AJ Vaccines, Ataulpho de Paiva, BioFarma, Biomed Lublin, GreenSignal Bio Pharma, IVAC, Japan BCG Lab, Microgen and Queen Saovabha Mem. Inst, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Tuberculosis Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Tuberculosis Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tuberculosis Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tuberculosis Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Tuberculosis Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Tuberculosis Vaccine Market by Company

AJ Vaccines

Ataulpho de Paiva

BioFarma

Biomed Lublin

GreenSignal Bio Pharma

IVAC

Japan BCG Lab

Microgen

Queen Saovabha Mem. Inst

Serum Institute of India

Taj Pharmaceuticals

Merck

China National Biotec

Tuberculosis Vaccine Segment by Type

Immune Vaccine

Therapy Vaccine

Tuberculosis Vaccine Segment by Application

Self-Procurement

UNICEF

Other

Tuberculosis Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tuberculosis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tuberculosis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tuberculosis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tuberculosis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Tuberculosis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Immune Vaccine Table 2. Major Company of Therapy Vaccine Table 3. Global Tuberculosis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Tuberculosis Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Tuberculosis Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Tuberculosis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Tuberculosis Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Tuberculosis Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Tuberculosis Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Tuberculosis Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Tuberculosis Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Tuberculosis Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Tuberculosis Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Tuberculosis Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Tuberculosis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Tuberculosis Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Tuberculosis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Tuberculosis Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Tuberculosis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Tuberculosis Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Tuberculosis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Tuberculosis Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Tuberculosis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Tuberculosis Vaccine Industry Trends Table 25. Tuberculosis Vaccine Industry Drivers Table 26. Tuberculosis Vaccine Industry Opportunities and Challenges Table 27. Tuberculosis Vaccine Industry Restraints Table 28. Global Tuberculosis Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Tuberculosis Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Tuberculosis Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Tuberculosis Vaccine Sales Share by Company (2021-2026) Table 32. Global Tuberculosis Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Tuberculosis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Tuberculosis Vaccine Major Company Production Sites and Headquarters Table 35. Global Tuberculosis Vaccine Company, Product Type & Application Table 36. Global Tuberculosis Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Tuberculosis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Tuberculosis Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Tuberculosis Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Tuberculosis Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Tuberculosis Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Tuberculosis Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Tuberculosis Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Tuberculosis Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Tuberculosis Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Tuberculosis Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Tuberculosis Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Tuberculosis Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Tuberculosis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Tuberculosis Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Tuberculosis Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Tuberculosis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Tuberculosis Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Tuberculosis Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Tuberculosis Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Tuberculosis Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Tuberculosis Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Tuberculosis Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Tuberculosis Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Tuberculosis Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Tuberculosis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Tuberculosis Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Tuberculosis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Tuberculosis Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Tuberculosis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Tuberculosis Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Tuberculosis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Tuberculosis Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Tuberculosis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. AJ Vaccines Company Information Table 72. AJ Vaccines Business Overview Table 73. AJ Vaccines Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AJ Vaccines Tuberculosis Vaccine Product Portfolio Table 75. AJ Vaccines Recent Development Table 76. Ataulpho de Paiva Company Information Table 77. Ataulpho de Paiva Business Overview Table 78. Ataulpho de Paiva Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Ataulpho de Paiva Tuberculosis Vaccine Product Portfolio Table 80. Ataulpho de Paiva Recent Development Table 81. BioFarma Company Information Table 82. BioFarma Business Overview Table 83. BioFarma Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. BioFarma Tuberculosis Vaccine Product Portfolio Table 85. BioFarma Recent Development Table 86. Biomed Lublin Company Information Table 87. Biomed Lublin Business Overview Table 88. Biomed Lublin Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Biomed Lublin Tuberculosis Vaccine Product Portfolio Table 90. Biomed Lublin Recent Development Table 91. GreenSignal Bio Pharma Company Information Table 92. GreenSignal Bio Pharma Business Overview Table 93. GreenSignal Bio Pharma Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. GreenSignal Bio Pharma Tuberculosis Vaccine Product Portfolio Table 95. GreenSignal Bio Pharma Recent Development Table 96. IVAC Company Information Table 97. IVAC Business Overview Table 98. IVAC Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. IVAC Tuberculosis Vaccine Product Portfolio Table 100. IVAC Recent Development Table 101. Japan BCG Lab Company Information Table 102. Japan BCG Lab Business Overview Table 103. Japan BCG Lab Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Japan BCG Lab Tuberculosis Vaccine Product Portfolio Table 105. Japan BCG Lab Recent Development Table 106. Microgen Company Information Table 107. Microgen Business Overview Table 108. Microgen Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Microgen Tuberculosis Vaccine Product Portfolio Table 110. Microgen Recent Development Table 111. Queen Saovabha Mem. Inst Company Information Table 112. Queen Saovabha Mem. Inst Business Overview Table 113. Queen Saovabha Mem. Inst Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Queen Saovabha Mem. Inst Tuberculosis Vaccine Product Portfolio Table 115. Queen Saovabha Mem. Inst Recent Development Table 116. Serum Institute of India Company Information Table 117. Serum Institute of India Business Overview Table 118. Serum Institute of India Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Serum Institute of India Tuberculosis Vaccine Product Portfolio Table 120. Serum Institute of India Recent Development Table 121. Taj Pharmaceuticals Company Information Table 122. Taj Pharmaceuticals Business Overview Table 123. Taj Pharmaceuticals Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Taj Pharmaceuticals Tuberculosis Vaccine Product Portfolio Table 125. Taj Pharmaceuticals Recent Development Table 126. Merck Company Information Table 127. Merck Business Overview Table 128. Merck Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Merck Tuberculosis Vaccine Product Portfolio Table 130. Merck Recent Development Table 131. China National Biotec Company Information Table 132. China National Biotec Business Overview Table 133. China National Biotec Tuberculosis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. China National Biotec Tuberculosis Vaccine Product Portfolio Table 135. China National Biotec Recent Development Table 136. North America Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Tuberculosis Vaccine Sales by Country (2021-2026) & (K Units) Table 138. North America Tuberculosis Vaccine Sales Market Share by Country (2021-2026) Table 139. North America Tuberculosis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Tuberculosis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. North America Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Tuberculosis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Tuberculosis Vaccine Market Share by Country (2021-2026) Table 144. North America Tuberculosis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Tuberculosis Vaccine Market Share Forecast by Country (2027-2032) Table 146. Europe Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Tuberculosis Vaccine Sales by Country (2021-2026) & (K Units) Table 148. Europe Tuberculosis Vaccine Sales Market Share by Country (2021-2026) Table 149. Europe Tuberculosis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Tuberculosis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Tuberculosis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Tuberculosis Vaccine Market Share by Country (2021-2026) Table 154. Europe Tuberculosis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Tuberculosis Vaccine Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Tuberculosis Vaccine Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Tuberculosis Vaccine Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Tuberculosis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Tuberculosis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Tuberculosis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Tuberculosis Vaccine Market Share by Country (2021-2026) Table 164. Asia-Pacific Tuberculosis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Tuberculosis Vaccine Market Share Forecast by Country (2027-2032) Table 166. Latin America Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Tuberculosis Vaccine Sales by Country (2021-2026) & (K Units) Table 168. Latin America Tuberculosis Vaccine Sales Market Share by Country (2021-2026) Table 169. Latin America Tuberculosis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Tuberculosis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Tuberculosis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Tuberculosis Vaccine Market Share by Country (2021-2026) Table 174. Latin America Tuberculosis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Tuberculosis Vaccine Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Tuberculosis Vaccine Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Tuberculosis Vaccine Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Tuberculosis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Tuberculosis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Tuberculosis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Tuberculosis Vaccine Market Share by Country (2021-2026) Table 184. Middle East and Africa Tuberculosis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Tuberculosis Vaccine Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Tuberculosis Vaccine Distributors List Table 189. Tuberculosis Vaccine Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Tuberculosis Vaccine Image Figure 2. Global Tuberculosis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tuberculosis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Tuberculosis Vaccine Sales (2021-2032) & (K Units) Figure 5. Immune Vaccine Image Figure 6. Global Immune Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 7. Therapy Vaccine Image Figure 8. Global Therapy Vaccine Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Tuberculosis Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Tuberculosis Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Tuberculosis Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Tuberculosis Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Tuberculosis Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Tuberculosis Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Tuberculosis Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Tuberculosis Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Tuberculosis Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Tuberculosis Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Tuberculosis Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Tuberculosis Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Tuberculosis Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Self-Procurement Image Figure 24. Global Self-Procurement Sales YoY Growth (2021-2032) & (K Units) Figure 25. UNICEF Image Figure 26. Global UNICEF Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Tuberculosis Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Tuberculosis Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America Tuberculosis Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America Tuberculosis Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe Tuberculosis Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe Tuberculosis Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Tuberculosis Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Tuberculosis Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America Tuberculosis Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Tuberculosis Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Tuberculosis Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Tuberculosis Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America Tuberculosis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Tuberculosis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Tuberculosis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Tuberculosis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Tuberculosis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Tuberculosis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Tuberculosis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Tuberculosis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Tuberculosis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Tuberculosis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Tuberculosis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Tuberculosis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Tuberculosis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Tuberculosis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Tuberculosis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Tuberculosis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Tuberculosis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Tuberculosis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Tuberculosis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Tuberculosis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Tuberculosis Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Tuberculosis Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Immune Vaccine
  • Therapy Vaccine
Applications
  • Self-Procurement
  • UNICEF
  • Other
Companies covered
  • AJ Vaccines
  • Ataulpho de Paiva
  • BioFarma
  • Biomed Lublin
  • GreenSignal Bio Pharma
  • IVAC
  • Japan BCG Lab
  • Microgen
  • Queen Saovabha Mem. Inst
  • Serum Institute of India
  • Taj Pharmaceuticals
  • Merck
  • China National Biotec

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Tuberculosis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Tuberculosis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Tuberculosis Vaccine Market by Type
  6. 1.3.1 Immune Vaccine
  7. 1.3.2 Therapy Vaccine
  8. 1.4 Global Tuberculosis Vaccine Market Size by Type
  9. 1.4.1 Global Tuberculosis Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Tuberculosis Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Tuberculosis Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Tuberculosis Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Tuberculosis Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Tuberculosis Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Tuberculosis Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Tuberculosis Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Tuberculosis Vaccine Industry Trends
  2. 2.2 Tuberculosis Vaccine Industry Drivers
  3. 2.3 Tuberculosis Vaccine Industry Opportunities and Challenges
  4. 2.4 Tuberculosis Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Tuberculosis Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Tuberculosis Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Tuberculosis Vaccine Price (2021-2026)
  4. 3.4 Global Tuberculosis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tuberculosis Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Tuberculosis Vaccine Company, Product Type & Application
  7. 3.7 Global Tuberculosis Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tuberculosis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tuberculosis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tuberculosis Vaccine Tier 1, Tier 2, and Tier 3
4 Tuberculosis Vaccine Regional Status and Outlook
  1. 4.1 Global Tuberculosis Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Tuberculosis Vaccine Historic Market Size by Region
  3. 4.2.1 Global Tuberculosis Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Tuberculosis Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Tuberculosis Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Tuberculosis Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Tuberculosis Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Tuberculosis Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Tuberculosis Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tuberculosis Vaccine by Application
  1. 5.1 Tuberculosis Vaccine Market by Application
  2. 5.1.1 Self-Procurement
  3. 5.1.2 UNICEF
  4. 5.1.3 Other
  5. 5.2 Global Tuberculosis Vaccine Market Size by Application
  6. 5.2.1 Global Tuberculosis Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Tuberculosis Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Tuberculosis Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Tuberculosis Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Tuberculosis Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Tuberculosis Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Tuberculosis Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Tuberculosis Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AJ Vaccines
  2. 6.1.1 AJ Vaccines Company Information
  3. 6.1.2 AJ Vaccines Business Overview
  4. 6.1.3 AJ Vaccines Tuberculosis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AJ Vaccines Tuberculosis Vaccine Product Portfolio
  6. 6.1.5 AJ Vaccines Recent Developments
  7. 6.2 Ataulpho de Paiva
  8. 6.2.1 Ataulpho de Paiva Company Information
  9. 6.2.2 Ataulpho de Paiva Business Overview
  10. 6.2.3 Ataulpho de Paiva Tuberculosis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Ataulpho de Paiva Tuberculosis Vaccine Product Portfolio
  12. 6.2.5 Ataulpho de Paiva Recent Developments
  13. 6.3 BioFarma
  14. 6.3.1 BioFarma Company Information
  15. 6.3.2 BioFarma Business Overview
  16. 6.3.3 BioFarma Tuberculosis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 BioFarma Tuberculosis Vaccine Product Portfolio
  18. 6.3.5 BioFarma Recent Developments
  19. 6.4 Biomed Lublin
  20. 6.4.1 Biomed Lublin Company Information
  21. 6.4.2 Biomed Lublin Business Overview
  22. 6.4.3 Biomed Lublin Tuberculosis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Biomed Lublin Tuberculosis Vaccine Product Portfolio
  24. 6.4.5 Biomed Lublin Recent Developments
  25. 6.5 GreenSignal Bio Pharma
  26. 6.5.1 GreenSignal Bio Pharma Company Information
  27. 6.5.2 GreenSignal Bio Pharma Business Overview
  28. 6.5.3 GreenSignal Bio Pharma Tuberculosis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GreenSignal Bio Pharma Tuberculosis Vaccine Product Portfolio
  30. 6.5.5 GreenSignal Bio Pharma Recent Developments
  31. 6.6 IVAC
  32. 6.6.1 IVAC Company Information
  33. 6.6.2 IVAC Business Overview
  34. 6.6.3 IVAC Tuberculosis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 IVAC Tuberculosis Vaccine Product Portfolio
  36. 6.6.5 IVAC Recent Developments
  37. 6.7 Japan BCG Lab
  38. 6.7.1 Japan BCG Lab Company Information
  39. 6.7.2 Japan BCG Lab Business Overview
  40. 6.7.3 Japan BCG Lab Tuberculosis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Japan BCG Lab Tuberculosis Vaccine Product Portfolio
  42. 6.7.5 Japan BCG Lab Recent Developments
  43. 6.8 Microgen
  44. 6.8.1 Microgen Company Information
  45. 6.8.2 Microgen Business Overview
  46. 6.8.3 Microgen Tuberculosis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Microgen Tuberculosis Vaccine Product Portfolio
  48. 6.8.5 Microgen Recent Developments
  49. 6.9 Queen Saovabha Mem. Inst
  50. 6.9.1 Queen Saovabha Mem. Inst Company Information
  51. 6.9.2 Queen Saovabha Mem. Inst Business Overview
  52. 6.9.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Queen Saovabha Mem. Inst Tuberculosis Vaccine Product Portfolio
  54. 6.9.5 Queen Saovabha Mem. Inst Recent Developments
  55. 6.10 Serum Institute of India
  56. 6.10.1 Serum Institute of India Company Information
  57. 6.10.2 Serum Institute of India Business Overview
  58. 6.10.3 Serum Institute of India Tuberculosis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Serum Institute of India Tuberculosis Vaccine Product Portfolio
  60. 6.10.5 Serum Institute of India Recent Developments
  61. 6.11 Taj Pharmaceuticals
  62. 6.11.1 Taj Pharmaceuticals Company Information
  63. 6.11.2 Taj Pharmaceuticals Business Overview
  64. 6.11.3 Taj Pharmaceuticals Tuberculosis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Taj Pharmaceuticals Tuberculosis Vaccine Product Portfolio
  66. 6.11.5 Taj Pharmaceuticals Recent Developments
  67. 6.12 Merck
  68. 6.12.1 Merck Company Information
  69. 6.12.2 Merck Business Overview
  70. 6.12.3 Merck Tuberculosis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Merck Tuberculosis Vaccine Product Portfolio
  72. 6.12.5 Merck Recent Developments
  73. 6.13 China National Biotec
  74. 6.13.1 China National Biotec Company Information
  75. 6.13.2 China National Biotec Business Overview
  76. 6.13.3 China National Biotec Tuberculosis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 China National Biotec Tuberculosis Vaccine Product Portfolio
  78. 6.13.5 China National Biotec Recent Developments
7 North America by Country
  1. 7.1 North America Tuberculosis Vaccine Sales by Country
  2. 7.1.1 North America Tuberculosis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Tuberculosis Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Tuberculosis Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Tuberculosis Vaccine Market Size by Country
  6. 7.2.1 North America Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Tuberculosis Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Tuberculosis Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Tuberculosis Vaccine Sales by Country
  2. 8.1.1 Europe Tuberculosis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Tuberculosis Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Tuberculosis Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Tuberculosis Vaccine Market Size by Country
  6. 8.2.1 Europe Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Tuberculosis Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Tuberculosis Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Tuberculosis Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Tuberculosis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Tuberculosis Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Tuberculosis Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Tuberculosis Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Tuberculosis Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Tuberculosis Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Tuberculosis Vaccine Sales by Country
  2. 10.1.1 South America Tuberculosis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Tuberculosis Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Tuberculosis Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Tuberculosis Vaccine Market Size by Country
  6. 10.2.1 South America Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Tuberculosis Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Tuberculosis Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Tuberculosis Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Tuberculosis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Tuberculosis Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Tuberculosis Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Tuberculosis Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Tuberculosis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Tuberculosis Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Tuberculosis Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Tuberculosis Vaccine Value Chain Analysis
  2. 12.1.1 Tuberculosis Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Tuberculosis Vaccine Production Mode & Process
  7. 12.2 Tuberculosis Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Tuberculosis Vaccine Distributors
  10. 12.2.3 Tuberculosis Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst